Mangiferin Improves Hepatic Lipid Metabolism Mainly Through Its Metabolite-Norathyriol by Modulating SIRT-1/AMPK/SREBP-1c Signaling.

about

L. and Its Flavonoids Regulate TNBS-Induced Inflammatory Bowel Disease through Anti-Inflammation and Suppressing Isolated Jejunum Contraction

P2860

Q57296619-7C25CC79-B6BE-48DD-8A79-45D8CF24CC5E

P2860

Mangiferin Improves Hepatic Lipid Metabolism Mainly Through Its Metabolite-Norathyriol by Modulating SIRT-1/AMPK/SREBP-1c Signaling.

Item

http://www.wikidata.org/entity/Q54981861

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Mangiferin Improves Hepatic Li ...... IRT-1/AMPK/SREBP-1c Signaling.

@en

Mangiferin Improves Hepatic Li ...... IRT-1/AMPK/SREBP-1c Signaling.

@nl

type

Item

label

Mangiferin Improves Hepatic Li ...... IRT-1/AMPK/SREBP-1c Signaling.

@en

Mangiferin Improves Hepatic Li ...... IRT-1/AMPK/SREBP-1c Signaling.

@nl

prefLabel

Mangiferin Improves Hepatic Li ...... IRT-1/AMPK/SREBP-1c Signaling.

@en

Mangiferin Improves Hepatic Li ...... IRT-1/AMPK/SREBP-1c Signaling.

@nl

P1476

Mangiferin Improves Hepatic Li ...... IRT-1/AMPK/SREBP-1c Signaling.

@en

P2093

Haiyang Yu

http://www.w3.org/2001/XMLSchema#string

Jian Li

http://www.w3.org/2001/XMLSchema#string

Jingya Ruan

http://www.w3.org/2001/XMLSchema#string

Lifeng Han

http://www.w3.org/2001/XMLSchema#string

Mengyang Liu

http://www.w3.org/2001/XMLSchema#string

Qian Chen

http://www.w3.org/2001/XMLSchema#string

Shaoshi Wen

http://www.w3.org/2001/XMLSchema#string

Tao Wang

http://www.w3.org/2001/XMLSchema#string

Wei Wang

http://www.w3.org/2001/XMLSchema#string

Yi Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation

The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress

Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c

Mangiferin decreases plasma free fatty acids through promoting its catabolism in liver by activation of AMPK

AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice

Molecular mediators of hepatic steatosis and liver injury

Treatment of nonalcoholic fatty liver disease: role of AMPK.

Scopolin ameliorates high-fat diet induced hepatic steatosis in mice: potential involvement of SIRT1-mediated signaling cascades in the liver

Increasing effect of Tangzhiqing formula on IRS-1-dependent PI3K/AKT signaling in muscle.

SIRT1 controls lipolysis in adipocytes via FOXO1-mediated expression of ATGL

P304

201

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPHAR.2018.00201

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29563875

http://www.w3.org/2001/XMLSchema#string

P932

5850072

http://www.w3.org/2001/XMLSchema#string

Mangiferin Improves Hepatic Lipid Metabolism Mainly Through Its Metabolite-Norathyriol by Modulating SIRT-1/AMPK/SREBP-1c Signaling.

about

P2860

P2860

Mangiferin Improves Hepatic Lipid Metabolism Mainly Through Its Metabolite-Norathyriol by Modulating SIRT-1/AMPK/SREBP-1c Signaling.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932